Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
10/31/2012 | CN1612750B TACI-immunoglobulin fusion proteins |
10/31/2012 | CN102762595A Antibodies to non-functional oligomeric p2x7 receptors |
10/31/2012 | CN102762577A 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
10/31/2012 | CN102762576A Benzoxazepin pi3k inhibitor compounds and methods of use |
10/31/2012 | CN102762574A Benzoxepin pi3k inhibitor compounds and methods of use |
10/31/2012 | CN102762571A Heterocyclic compounds as janus kinase inhibitors |
10/31/2012 | CN102762570A Pyrazole derivatives as JAK inhibitors |
10/31/2012 | CN102762569A Benzodiazepine bromodomain inhibitor |
10/31/2012 | CN102762565A Pyrido[3,2-d]pyrimidine PI3[delta] inhibitor compounds and methods of use |
10/31/2012 | CN102762563A Pyrazolo piperidine derivatives as nadph oxidase inhibitors |
10/31/2012 | CN102762558A Pyridine-pyridinone derivatives, preparation and therapeutic use thereof |
10/31/2012 | CN102762557A Triazolopyridines |
10/31/2012 | CN102762537A Novel phenol derivatives and pharmaceutical or cosmetic use thereof |
10/31/2012 | CN102762535A Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
10/31/2012 | CN102762230A Novel radioimmunoconjugates and uses thereof |
10/31/2012 | CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
10/31/2012 | CN102762214A Modulation of epidermal growth factor receptor ligands |
10/31/2012 | CN102762213A Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors |
10/31/2012 | CN102762202A Taxane pro-emulsion formulations and methods making and using the same |
10/31/2012 | CN102757961A Method of siRNA sequence chemical modification, product thereof, and application of product thereof |
10/31/2012 | CN102757938A Application of VSTM1 protein in preparation of product for promoting differentiation of leukemic cells |
10/31/2012 | CN102757908A Streptomyces sp., indole sesquiterpenoids, and preparation method and application of indole sesquiterpenoids to preparation of antibacterial and antitumor medicament |
10/31/2012 | CN102757564A Preparation method and application of tree-like polyester-polyglycidol block polymer |
10/31/2012 | CN102757555A Dequalinium chloride-polyethylene glycol-distearoyl phosphatidyl ethanolamine conjugated compound and resveratrol liposome modified thereby |
10/31/2012 | CN102757515A Method for extracting high-purity flavonoid and pectin from citrus peel |
10/31/2012 | CN102757511A Grifola frondosa galactan and preparation method thereof |
10/31/2012 | CN102757510A Low-molecular weight schisandra chinensis polysaccharides and preparation method and application thereof |
10/31/2012 | CN102757503A Preparation method and application of human prostate apoptosis response protein 4 and apoptin 2 ligand fusion protein |
10/31/2012 | CN102757500A Pegylation modifier of long-acting thymosin alpha1 |
10/31/2012 | CN102757495A Holistic anti-VEGF antibody, preparation method and application thereof |
10/31/2012 | CN102757482A Polypeptide and application thereof |
10/31/2012 | CN102757476A Preparation method and application of squid ink peptidoglycan |
10/31/2012 | CN102757460A Dihydroartemisinin sesquioxide germanium compound and preparation method as well as application thereof |
10/31/2012 | CN102757448A Macrocyclic kinase inhibitor compound, preparation method and application thereof as drug |
10/31/2012 | CN102757443A Sulfur-substituted podophyllum derivative and bioconversion, separation and purification method thereof |
10/31/2012 | CN102757442A Sulfur-substituted podophyllum derivative and synthetic method and application thereof |
10/31/2012 | CN102757441A Furano[3,2-g]chromene compounds and applications thereof |
10/31/2012 | CN102757435A Trans-3-indolyl-4-pyrroldiazepinecycloheptane-2,5-pyrrolidine-2,5-diketone compound and preparation method thereof |
10/31/2012 | CN102757425A Novel lipoic octanoylhydrazide derivative, preparation method and application thereof |
10/31/2012 | CN102757424A 2-benzyl-substituted-benzofuran-imidazolium compounds and preparation method thereof |
10/31/2012 | CN102757417A Deuterated benzopyran compound and application thereof |
10/31/2012 | CN102755651A Anti-skin squamous cell carcinoma medicament, i.e., antagomir-365-2 |
10/31/2012 | CN102755646A Medicament for treating TNF alpha related disorder |
10/31/2012 | CN102755632A Secretory protein related to cell viability and coding gene and application of secretory protein related to cell viability |
10/31/2012 | CN102755627A Method for preparing goserelin slow-release implant |
10/31/2012 | CN102755600A Traditional Chinese medicine compound for resisting breast cancer metastasis and reoccurrence |
10/31/2012 | CN102755539A Traditional Chinese medicine liniment for retaining carcinoma and relieving pain |
10/31/2012 | CN102755512A Traditional Chinese medicine extract capable of improving CIK cell proliferation rate as well as preparation method and application of same |
10/31/2012 | CN102755418A Medicinal composition for treating precancerous lesions of chronic atrophic gastritis and preparation method thereof |
10/31/2012 | CN102755404A Method for decocting Chinese magnoliavine fruit |
10/31/2012 | CN102755402A Composition used for treating lung cancer, preparation method thereof, and purpose thereof |
10/31/2012 | CN102755381A Traditional Chinese medicine composition for treating malignant tumor and preparation method of composition |
10/31/2012 | CN102755376A Preparing method of licorice |
10/31/2012 | CN102755359A Hippophae extract and preparation method and application thereof for inhibiting activity of fatty acid synthase |
10/31/2012 | CN102755357A Application of paecilomyces cicada conidiophore to preparation of antitumor medicament |
10/31/2012 | CN102755354A Fusarium oxysporum extract and application thereof |
10/31/2012 | CN102755346A Compound polysaccharide formula of edible fungus as well as preparation method and application thereof |
10/31/2012 | CN102755345A Application of compounds inhibiting cell cycle progression in preparation of drug inhibiting or removing double minute chromosomes in tumor cells |
10/31/2012 | CN102755344A Quercetin medicine gastric-retention preparation |
10/31/2012 | CN102755326A Application of quetiapine to preparation of medicament for treating glioma |
10/31/2012 | CN102755318A Hyperproliferative disorders with diarylhydantoin compounds |
10/31/2012 | CN102755314A Pharmaceutical composition taking podophyllotoxin as main active component and preparation method of same |
10/31/2012 | CN102755298A Preparation method and application of resveratrol freeze-dried polymer micelle |
10/31/2012 | CN102755292A Vesicle-type medication system containing metformin, and application thereof |
10/31/2012 | CN102754832A Disease curing method for melting tumor and transforming cancer cells by using phenol and quinone |
10/31/2012 | CN102391345B Pseuoginsenoside-Rh 2 and application in preparation of tumor treating medicine |
10/31/2012 | CN102258526B Anticancer medicinal composition |
10/31/2012 | CN102228593B Chinese herbal medicine prescription for treating esophagus cancer, and preparation method thereof |
10/31/2012 | CN102206291B Process for extracting yam polysaccharide by using supercritical CO2 fluid extraction technique |
10/31/2012 | CN102145135B Process for extracting bamboo leaf coarse polysaccharide by supercritical CO2 fluid extraction technology |
10/31/2012 | CN102091027B Method for preparing antitumor small interfering RNA carrying magnetic nano probe |
10/31/2012 | CN102070510B 3-hydroxyindole derivatives and synthesis method and use thereof |
10/31/2012 | CN102000340B Targeted polymer medicament carrier and preparation method and application thereof |
10/31/2012 | CN101999648B Extraction method of anthocyanin and original anthocyanin components in cranberry fruits |
10/31/2012 | CN101972478B 抗体治疗 Antibody therapy |
10/31/2012 | CN101940793B Hydroxypropyl-beta-cyclodextrin clathrate compound of cantharidin and cantharis extractive and preparation method thereof |
10/31/2012 | CN101927008B Diagnostic and therapeutic gastric cancer vascular specific binding peptide GEBP11 isotope probe |
10/31/2012 | CN101850122B Cholesterylchitosan nano carrier as well as medicament-carried nano particle and preparation method thereof |
10/31/2012 | CN101723896B Tyrosine derivative histone deacetylases inhibitor and application thereof |
10/31/2012 | CN101721545B Anti-tumor Chinese medicinal composition and preparation method thereof |
10/31/2012 | CN101563365B Anti-IL-6 monoclonal antibodies and uses thereof |
10/31/2012 | CN101538311B Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof |
10/31/2012 | CN101511842B Dihydrofuro pyrimidines as AKT protein kinase inhibitors |
10/31/2012 | CN101395171B Steroidal compounds as steroid sulphatase inhibitors |
10/31/2012 | CN101365486B Combination therapy using anti-EGFR and anti-HER2 antibodies |
10/31/2012 | CN101356173B Novel pyridopyrazines and their use as modulators of kinases |
10/31/2012 | CN101318022B Metal-polysaccharide conjugates and synthesis method |
10/31/2012 | CN101312960B F,G,H,I and K crystal forms of imatinib mesylate |
10/31/2012 | CN101287712B Heterocyclic compounds |
10/31/2012 | CN101142198B Isoxazole combretastatin derivatives for the treatment of disorders |
10/31/2012 | CN101035808B Humanized anti-CMET antagonists |
10/30/2012 | US8299234 siRNA hat inhibits WT1 gene expression and uses thereof |
10/30/2012 | US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
10/30/2012 | US8299121 Softgel of NLKJ for treating prostate diseases |
10/30/2012 | US8299116 CCI-779 concentrate formulations |
10/30/2012 | US8299108 Substituted benzazoles and methods of their use as inhibitors of raf kinase |
10/30/2012 | US8299088 Compositions and methods for treating cancer |
10/30/2012 | US8299076 Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide |
10/30/2012 | US8299030 Peptide-based compounds |
10/30/2012 | US8298817 Vector |